Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 08, 2020 10:30 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Adds Israel Rights to Movantik® From AstraZeneca

RedHill obtains Israel rights to Movantik® from AstraZeneca, giving RedHill global rights, excluding Europe and Canada--Movantik approved for opioid-induced constipation in Israel under the brand name...
August 03, 2020 07:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Announces New Agreement with Daiichi Sankyo for Movantik®

RedHill acquired Movantik® for opioid induced constipation from AstraZeneca in April 2020; Movantik® generated $96 million in 2019 --RedHill and Daiichi Sankyo replaced their co-commercialization...